LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 139 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 6.44 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $100,368 | -16.1% | 59,743 | +19.9% | 0.00% | – |
Q1 2024 | $119,564 | +27.7% | 49,818 | -18.6% | 0.00% | – |
Q4 2023 | $93,609 | +65.4% | 61,182 | +17.8% | 0.00% | – |
Q3 2023 | $56,611 | -38.4% | 51,937 | +29.5% | 0.00% | – |
Q2 2023 | $91,868 | -7.7% | 40,117 | -2.1% | 0.00% | – |
Q1 2023 | $99,562 | +26.5% | 40,972 | -0.6% | 0.00% | – |
Q4 2022 | $78,736 | +5.0% | 41,223 | +31.5% | 0.00% | – |
Q3 2022 | $75,000 | +41.5% | 31,353 | +9.9% | 0.00% | – |
Q2 2022 | $53,000 | -14.5% | 28,523 | -4.4% | 0.00% | – |
Q1 2022 | $62,000 | -45.1% | 29,849 | +3.7% | 0.00% | – |
Q4 2021 | $113,000 | -15.0% | 28,778 | +3.7% | 0.00% | – |
Q3 2021 | $133,000 | +25.5% | 27,753 | +19.7% | 0.00% | – |
Q2 2021 | $106,000 | +45.2% | 23,185 | +85.9% | 0.00% | – |
Q1 2021 | $73,000 | -34.8% | 12,471 | -62.0% | 0.00% | – |
Q4 2020 | $112,000 | +239.4% | 32,824 | +39.5% | 0.00% | – |
Q3 2020 | $33,000 | -29.8% | 23,526 | +0.4% | 0.00% | – |
Q2 2020 | $47,000 | -75.4% | 23,435 | -31.8% | 0.00% | – |
Q1 2019 | $191,000 | -10.7% | 34,338 | +6.4% | 0.00% | – |
Q4 2018 | $214,000 | -48.2% | 32,261 | -16.6% | 0.00% | – |
Q3 2018 | $413,000 | +19.7% | 38,667 | +34.3% | 0.00% | – |
Q2 2018 | $345,000 | +189.9% | 28,782 | +107.6% | 0.00% | – |
Q1 2018 | $119,000 | -0.8% | 13,866 | +13.8% | 0.00% | – |
Q4 2017 | $120,000 | -18.4% | 12,181 | +1.9% | 0.00% | – |
Q3 2017 | $147,000 | -20.5% | 11,954 | +6.2% | 0.00% | – |
Q2 2017 | $185,000 | -97.0% | 11,260 | -97.4% | 0.00% | -100.0% |
Q1 2017 | $6,116,000 | -13.1% | 426,534 | -16.1% | 0.00% | 0.0% |
Q4 2016 | $7,034,000 | -36.7% | 508,590 | -17.2% | 0.00% | -50.0% |
Q3 2016 | $11,106,000 | +25.6% | 614,606 | -0.3% | 0.00% | +33.3% |
Q2 2016 | $8,844,000 | -3.9% | 616,278 | -20.0% | 0.00% | -25.0% |
Q1 2016 | $9,206,000 | +429.1% | 770,370 | +489.4% | 0.00% | +300.0% |
Q4 2015 | $1,740,000 | +23.0% | 130,709 | -0.8% | 0.00% | 0.0% |
Q3 2015 | $1,415,000 | +28200.0% | 131,768 | +19277.6% | 0.00% | – |
Q2 2015 | $5,000 | – | 680 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ulys, L.L.C. | 4,321,214 | $46,410,000 | 99.99% |
Artal Group S.A. | 57,517,978 | $617,743,000 | 13.80% |
ACUTA CAPITAL PARTNERS, LLC | 400,000 | $4,296,000 | 2.49% |
BRIDGER MANAGEMENT, LLC | 1,292,368 | $13,880,000 | 0.95% |
Rhenman & Partners Asset Management AB | 200,000 | $2,148,000 | 0.34% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 525,000 | $5,639,000 | 0.27% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 400,000 | $4,296,000 | 0.21% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $384,000 | 0.19% |
MASTERS CAPITAL MANAGEMENT LLC | 500,000 | $5,370,000 | 0.18% |
Round Table Services, LLC | 21,611 | $232,000 | 0.17% |